Fig 29 in each curve fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Fig 9(b) in the straight-line fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Specimen packaging process. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Relationship between τ_<i>i</i> and σ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

The relationship between Δσ_n and τ₁, <i>JRC</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Relationship between τ_<i>i</i> and σ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

(a) Comparison of the approximate solution with the exact solution for the example 1. by Lahoucine Tadoummant (21647670)

(a) Comparison of the approximate solution with the exact solution for the example 2. by Lahoucine Tadoummant (21647670)

SEM images of alkali-activated samples JW1 at a magnification of ×5000. by Liang Li (46069)

SEM images of alkali-activated samples JW3 at a magnification of ×5000. by Liang Li (46069)

Point load strength apparatus: (a) before modification; (b) after modification. by Hong Zhang (25820)

SEM images of alkali-activated samples JW1 at a magnification of ×5000. by Liang Li (46069)

SEM images of alkali-activated samples JW3 at a magnification of ×5000. by Liang Li (46069)

Frontier analysis findings: (A) A frontier analysis diagram based on Age-Standardized DALYs Rate (ASDR) and the SDI from 1990 to 2021. by Guanghui Yu (423945)

Estimated coefficients from the SARIMA model of new COVID-19 deaths assuming a gradual effect following the implementation of two ETSs and one executive order in Oregon. by Raul Cruz-Cano (3751321)

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Difference in various variables with different PA level. by Zixia Bu (21475019)

Demographic information of participants. by Zixia Bu (21475019)

“…The longitudinal results showed a decreasing trend of negative correlation between AB and PA under T1-T3 stages (r = −0.29, r = −0.44, P < 0.01), and no significant change in the degree of negative correlation with HSK (r = −0.28, r = −0.35, P < 0.01). …”

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P_i‐induced VSMCs. …”

Development of alpha diversity across weeks towards a new TNF treatment for each IBD disease subtype. by Katrine Carlsen (5477300)